Hellman Jordan Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.55M | Buy |
5,349
+708
| +15% | +$204K | 2.62% | 16 |
|
|
2022
Q3 | $1.34M | Sell |
4,641
-2,011
| -30% | -$582K | 2.33% | 17 |
|
|
2022
Q2 | $1.87M | Buy |
6,652
+1,786
| +37% | +$503K | 2.52% | 9 |
|
|
2022
Q1 | $1.27M | Sell |
4,866
-2,921
| -38% | -$762K | 1.38% | 25 |
|
|
2021
Q4 | $1.71M | Sell |
7,787
-3,074
| -28% | -$675K | 2.05% | 18 |
|
|
2021
Q3 | $1.97M | Buy |
10,861
+3,346
| +45% | +$607K | 2.77% | 9 |
|
|
2021
Q2 | $1.52M | Buy |
7,515
+11
| +0.1% | +$2.22K | 2.69% | 8 |
|
|
2021
Q1 | $1.61M | Buy |
7,504
+6,580
| +712% | +$1.41M | 2.34% | 11 |
|
|
2020
Q4 | $218K | Buy |
924
+70
| +8% | +$16.5K | 0.69% | 18 |
|
|
2020
Q3 | $232K | Buy |
854
+18
| +2% | +$4.89K | 0.44% | 17 |
|
|
2020
Q2 | $243K | Sell |
836
-6
| -0.7% | -$1.74K | 0.39% | 19 |
|
|
2020
Q1 | $200K | Buy |
+842
| New | +$200K | 0.47% | 20 |
|